Ogibiotec provides an integrated biologics manufacturing platform that automates strain engineering, high‑throughput bioreactor screening, and scalable fermentation, delivering consistent protein‑based therapeutic production from bench to commercial scale. The cloud‑based analytics dashboard and FDA‑compliant electronic batch records streamline process optimization and regulatory documentation, allowing pharma and biotech companies to accelerate development while reducing costs. Access is offered via subscription, per‑batch fees, or managed‑service contracts.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical and biotech companies often face lengthy, costly, and inefficient processes for developing and scaling biologic production, leading to delayed time‑to‑market and high R&D expenditures.
Solution
Ogibiotec offers an integrated biologics manufacturing platform that streamlines strain engineering, process development, and scale‑up for protein‑based therapeutics. The platform combines automated genome editing tools with high‑throughput screening to rapidly identify high‑yield cell lines. Optimized fermentation protocols and real‑time process analytics enable consistent production at pilot and commercial scales. Integrated data management and regulatory‑compliant documentation reduce the burden of compliance and accelerate the transition from development to manufacturing. Clients can access the platform via a subscription model or as a managed service, allowing them to focus on product innovation while Ogibiotec handles the manufacturing workflow.
Target Audience
Primary customers are pharmaceutical manufacturers, biotech startups, and contract development and manufacturing organizations (CDMOs) seeking faster, cost‑effective biologics production.
Features
- Automated CRISPR‑based genome editing pipelines for rapid cell‑line generation
- High‑throughput bioreactor screening with inline optical and metabolic sensors
- Scalable fermentation recipes adaptable from 1 L bench to 10,000 L production
- Cloud‑based process analytics dashboard with AI‑driven yield optimization
- End‑to‑end electronic batch records meeting FDA 21 CFR Part 11 requirements
- Flexible deployment options: on‑premise equipment, cloud‑managed service, or hybrid model